Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1643918 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.45Day +0.35%1Y −96.6%Off 52W high −97.6%Vol (1Y) 175.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 833 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.00% |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-£6.4M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (GBP). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−87.3% |
| 1Y−96.6% |
| 3Y−100.0% |
| Since incept. (ann.)−95.5% |
Price return through 2026-07-29 · series begins 2023-03-27. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)175.7% |
| Ann. volatility (3Y)182.4% |
| Sharpe (1Y)−1.17 |
| Sharpe (3Y)−0.78 |
| Max drawdown (1Y)−97.4% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)2.03 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 257,472 | $159,092 | 0.00% | +35.0% |
| ARMISTICE CAPITAL, LLC | 97,521 | $60,258 | 0.00% | −2.5% |
| GAMMA Investing LLC | 13,780 | $8,515 | 0.00% | +675.5% |
| SBI Securities Co., Ltd. | 151 | $93 | 0.00% | +49.5% |
| UBS Group AG | 127 | $78 | 0.00% | −94.0% |
| Hilton Head Capital Partners, LLC | 30 | $19 | 0.00% | +0.0% |
| RHUMBLINE ADVISERS | 19 | $11 | 0.00% | −20.8% |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for BDRX.
